Intelligence Β· Clinical Pipeline
Bial Portela & Pipeline
All ClinicalTrials.gov programs at Bial Portela & β phase, modality, and trial IDs.
- Programs
- 7
Quick answer
Bial Portela & has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Eslicarbazepine acetate (BIA 2-093)
Bial Portela & Companhia S.A.
Partial Epilepsy in Children and Adolescents
1 trial -
GLUCOPHAGE 500 mg tabletki powlekane, Placebo
Bial Portela & Companhia S.A.
papillary thyroid carcinoma
1 trial -
PSMA-11 kit for Ga-68 labelling
Bial Portela & Companhia S.A.
Intermediate and high-risk prostate cancer
1 trial -
Placebo, Atoris, 40 mg, tabletki powlekane
Bial Portela & Companhia S.A.
Chronic obstructive pulmonary disease (COPD)
1 trial -
Placebo, Minirin, 4 mikrogramy/ml, roztwΓ³r do wstrzykiwaΕ
Bial Portela & Companhia S.A.
Rare and ultra-rare glomerulonephritis
1 trial -
Placebo, GLUCOPHAGE 500 mg tabletki powlekane
Bial Portela & Companhia S.A.
idiopathic infertility
1 trial -
Phase I, Open-Label Study to Evaluate the Pharmacokinetics, Safety and Tolerability of BIA 28-6156 in Participants with Varying Degrees of Renal Impairment
Bial Portela & Companhia S.A.
Parkinson's disease
1 trial
Frequently asked questions
How many pipeline programs does Bial Portela & have?
7 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources Β· All pipeline programs